CeriBell, Inc. Common Stock (CBLL)

• Market cap: $644M
• 1 day: -5.01%
• 5 days: -4.06%
• 1 month: 4.04%
• 3 months: -19.30%
• 6 months: -40.90%
• Year to date: -33.22%
• 1 year: -30.92%
• 5 years: -30.92%
• 10 years: -30.92%
• Sector: Healthcare
• Industry: Medical Devices

About: CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Employees: 281

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

21% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 19

10% more funds holding

Funds holding: 78 [Q4 2024] → 86 (+8) [Q1 2025]

2.71% more ownership

Funds ownership: 64.47% [Q4 2024] → 67.17% (+2.71%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q4 2024] → 4 (+0) [Q1 2025]

23% less capital invested

Capital invested by funds: $598M [Q4 2024] → $463M (-$135M) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $32 85% upside
• Avg. target: $32 85% upside
• High target: $32 85% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Ladenburg Thalmann Jeff Cohen

85% upside $32

Buy Initiated

4 Apr 2025